Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLungCancerTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLungCancerTeam Member asked a question πŸ’­
New York, NY
August 30
 · 
Be the first to react
MyLungCancerTeam

Can Keytruda cause ground glass nodules on the lungs? This is a really important question to explore.

Keytruda (pembrolizumab) is an immunotherapy that works by helping your immune system attack cancer cells. One known side effect is pneumonitis β€” inflammation of the lung tissue β€” which can show up on scans as ground-glass Show Full Answer

Can Keytruda cause ground glass nodules on the lungs? This is a really important question to explore.

Keytruda (pembrolizumab) is an immunotherapy that works by helping your immune system attack cancer cells. One known side effect is pneumonitis β€” inflammation of the lung tissue β€” which can show up on scans as ground-glass opacities (hazy, frosted-glass-looking areas).

These ground-glass changes are not the same as nodules, but they can look similar on imaging. They are worth taking seriously. A MyLungCancerTeam member shared their experience developing pneumonitis as a reaction to their lung cancer medication, which led to hospitalization and a prolonged recovery involving steroids and antibiotics.

If you notice new or worsening symptoms like:

- Shortness of breath
- A new or worsening cough
- Chest pain or discomfort
- Fever

...it's really important to contact your oncology team right away. Pneumonitis from immunotherapy can be serious but is manageable when caught early. Don't wait on this one β€” reach out to your care team promptly.

August 30

Related Questions

View All
A MyLungCancerTeam Member asked a question πŸ’­